在住院期间急性心肌梗塞后,估计的淋巴细胞过率的降低作为心室动脉节律失常的危险因素:回顾性倾向评分与队列研究相匹配
Ming Li1, Chongzhou Zheng1, Chunmei Chen1
1Department of Cardiology, Affiliated Hospital of Guangdong Medical University, 524001 Zhanjiang, Guangdong, China.
降低估计的膜过率 (eGFR) 是急性心肌梗塞 (AMI) 后心室动脉节律失常症 (VTA) 的重要独立风险因素. 这一发现强调了监测AMI患者的功能的重要性,以预测和预防VTA.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 临床研究 临床研究
背景情况:
- 在急性心肌梗塞 (AMI) 之后,心室动脉节律失常 (VTA) 构成显著的风险.
- 估计膜过率 (eGFR) 作为AMI患者VTA的独立预测因子的作用需要进一步澄清.
研究的目的:
- 为了研究降低eGFR和AMI患者中静脉动脉的发病率之间的关联.
- 确定降低eGFR是否是AMI后VTA的独立风险因素.
主要方法:
- 在2017年1月至2019年12月期间诊断出AMI的503名患者的回顾性分析.
- 使用奇平方测试和倾向分数匹配 (PSM) 来调整混因素和基线特征.
- 进行了单变物流回归分析,以评估PSM前后的eGFR和VTA之间的关系.
主要成果:
- 倾向性得分与组之间的成功平衡的基线特征相匹配,在91名降低eGFR的患者中,有86名患者匹配.
- 尽管匹配,但VTA发病率在各组之间仍然存在显著差异 (p < 0.001).
- 统变逻辑回归显示,降低eGFR与VTA相关,PSM前的赔率比为6.442,PSM后的赔率比为3.654.
结论:
- 降低eGFR (<60毫升/分钟/1.73米2) 是 AMI 患者中 VTA 的独立风险因素.
- 监测eGFR对于AMI幸存者的风险分层和VTA管理至关重要.
更多相关视频
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
03:13Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research
Published on: November 3, 2023
相关概念视频
Glomerular Filtration Rate and its Regulation
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Increased pulse rate
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
